5-methyl-N-(4-(2-(pyrazolo[1,5-a]pyridin-2-yl)-5,6-dihydro-4H-benzo[b]thieno[2,3-d]azepine-6-carbonyl)phenyl)-2-(7-oxa-2-azaspiro[3.5]nonan-2-yl)nicotinamide

ID: ALA4083646

PubChem CID: 137645828

Max Phase: Preclinical

Molecular Formula: C40H36N6O3S

Molecular Weight: 680.83

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cnc(N2CC3(CCOCC3)C2)c(C(=O)Nc2ccc(C(=O)N3CCc4cc(-c5cc6ccccn6n5)sc4-c4ccccc43)cc2)c1

Standard InChI:  InChI=1S/C40H36N6O3S/c1-26-20-32(37(41-23-26)44-24-40(25-44)14-18-49-19-15-40)38(47)42-29-11-9-27(10-12-29)39(48)45-17-13-28-21-35(33-22-30-6-4-5-16-46(30)43-33)50-36(28)31-7-2-3-8-34(31)45/h2-12,16,20-23H,13-15,17-19,24-25H2,1H3,(H,42,47)

Standard InChI Key:  OJJQNLJUUMTIBI-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 50 58  0  0  0  0  0  0  0  0999 V2000
   15.6587  -19.2288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3645  -18.8160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3599  -18.0030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6513  -17.5965    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.9455  -18.0092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9484  -18.8284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9639  -21.6101    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.9628  -22.4297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6708  -22.8386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3805  -22.4292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3776  -21.6065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6690  -21.2013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6666  -20.3841    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.2394  -19.8073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0838  -19.8107    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0838  -21.1953    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7931  -21.6012    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.0807  -20.3781    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.4992  -21.1899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2069  -21.5993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9126  -21.1887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9099  -20.3706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1957  -19.9649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4929  -20.3778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6155  -19.9584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3253  -20.3634    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.6114  -19.1412    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.3508  -18.7803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5270  -17.9809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8829  -18.7929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6928  -17.9930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9065  -17.7592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3096  -18.3244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5044  -19.1264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2904  -19.3564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1900  -17.3511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0105  -17.3464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2596  -16.5646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5930  -16.0860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9320  -16.5722    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   20.5854  -15.2681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2437  -14.7839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9215  -14.7915    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.1695  -14.0129    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.9845  -14.0105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3882  -13.3046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9780  -12.6005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1599  -12.6069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7598  -13.3134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6706  -23.6558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
 12 13  1  0
 13 14  1  0
 14  1  1  0
  1 15  1  0
 15 13  1  0
 11 16  1  0
 16 17  1  0
 16 18  2  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 22 25  1  0
 25 26  2  0
 25 27  1  0
 27 30  1  0
 27 28  1  0
 31 36  1  0
 28 29  1  0
 29 37  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  2  0
 35 30  1  0
 36 37  2  0
 37 38  1  0
 38 39  2  0
 39 40  1  0
 40 36  1  0
 41 42  1  0
 42 45  2  0
 44 43  1  0
 43 41  2  0
 39 41  1  0
 44 45  1  0
 45 46  1  0
 46 47  2  0
 47 48  1  0
 48 49  2  0
 49 44  1  0
  9 50  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4083646

    ---

Associated Targets(Human)

HEp-2 (3859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 680.83Molecular Weight (Monoisotopic): 680.2570AlogP: 7.51#Rotatable Bonds: 5
Polar Surface Area: 92.07Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 5.41CX LogP: 7.08CX LogD: 7.08
Aromatic Rings: 6Heavy Atoms: 50QED Weighted: 0.20Np Likeness Score: -1.44

References

1. Fordyce EAF, Brookes DW, Lise-Ciana C, Coates MS, Hunt SF, Ito K, King-Underwood J, Onions ST, Parra GF, Rapeport G, Sherbukhin V, Stockwell JA, Strong P, Thomas JC, Murray J..  (2017)  Discovery of novel benzothienoazepine derivatives as potent inhibitors of respiratory syncytial virus.,  27  (10): [PMID:28372911] [10.1016/j.bmcl.2017.03.053]

Source